Reilly Herbert Faulkner III Decreases Stock Position in UnitedHealth Group Inc (NYSE:UNH)

Reilly Herbert Faulkner III cut its stake in UnitedHealth Group Inc (NYSE:UNH) by 8.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,970 shares of the healthcare conglomerate’s stock after selling 180 shares during the period. Reilly Herbert Faulkner III’s holdings in UnitedHealth Group were worth $428,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the stock. Northern Trust Corp boosted its holdings in UnitedHealth Group by 0.4% in the second quarter. Northern Trust Corp now owns 12,111,540 shares of the healthcare conglomerate’s stock valued at $2,955,336,000 after purchasing an additional 53,710 shares during the period. Nuveen Asset Management LLC boosted its holdings in UnitedHealth Group by 1,354.6% in the second quarter. Nuveen Asset Management LLC now owns 8,540,562 shares of the healthcare conglomerate’s stock valued at $2,083,983,000 after purchasing an additional 7,953,416 shares during the period. Janus Henderson Group PLC boosted its holdings in UnitedHealth Group by 16.7% in the second quarter. Janus Henderson Group PLC now owns 6,448,289 shares of the healthcare conglomerate’s stock valued at $1,573,438,000 after purchasing an additional 922,290 shares during the period. Viking Global Investors LP boosted its holdings in UnitedHealth Group by 28.6% in the second quarter. Viking Global Investors LP now owns 4,812,185 shares of the healthcare conglomerate’s stock valued at $1,174,221,000 after purchasing an additional 1,071,149 shares during the period. Finally, Sanders Capital LLC boosted its holdings in UnitedHealth Group by 50.2% in the second quarter. Sanders Capital LLC now owns 4,626,666 shares of the healthcare conglomerate’s stock valued at $1,255,689,000 after purchasing an additional 1,546,140 shares during the period. Hedge funds and other institutional investors own 85.66% of the company’s stock.

In other news, CAO Thomas E. Roos sold 1,177 shares of the business’s stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $255.04, for a total value of $300,182.08. Following the completion of the sale, the chief accounting officer now directly owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn bought 2,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, August 28th. The stock was purchased at an average cost of $227.55 per share, with a total value of $455,100.00. Following the completion of the acquisition, the director now directly owns 5,524 shares in the company, valued at approximately $1,256,986.20. The disclosure for this purchase can be found here. Insiders sold a total of 33,177 shares of company stock valued at $7,842,582 over the last three months. Company insiders own 0.87% of the company’s stock.

NYSE UNH traded up $0.51 during trading on Friday, reaching $256.97. 2,161,274 shares of the company’s stock were exchanged, compared to its average volume of 4,544,972. The stock has a market cap of $237.20 billion, a P/E ratio of 19.95, a price-to-earnings-growth ratio of 1.33 and a beta of 0.61. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.67 and a current ratio of 0.70. The company has a 50 day moving average price of $234.76 and a two-hundred day moving average price of $241.05. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The company had revenue of $60.35 billion during the quarter, compared to the consensus estimate of $59.84 billion. During the same period in the previous year, the business earned $3.41 EPS. UnitedHealth Group’s revenue for the quarter was up 6.7% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Inc will post 14.96 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $1.08 dividend. This represents a $4.32 annualized dividend and a dividend yield of 1.68%. UnitedHealth Group’s payout ratio is currently 33.54%.

A number of research analysts recently issued reports on UNH shares. Cleveland Research reiterated a “buy” rating on shares of UnitedHealth Group in a report on Monday, July 15th. Jefferies Financial Group downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $300.00 to $235.00 in a report on Thursday, October 10th. Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price target for the company in a report on Monday, July 22nd. Barclays set a $260.00 price target on UnitedHealth Group and gave the stock a “buy” rating in a report on Tuesday, October 8th. Finally, UBS Group decreased their price target on UnitedHealth Group from $281.00 to $257.00 and set a “neutral” rating for the company in a report on Thursday, October 17th. Five research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $283.84.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: What moving averages are used to define a golden cross?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.